GridPP4: The UK Grid for Particle Physics
Lead Research Organisation:
Queen Mary University of London
Department Name: Physics
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
People |
ORCID iD |
Stephen Lloyd (Principal Investigator) | |
Alex Martin (Co-Investigator) |
Publications
Aad G
(2013)
Search for long-lived, multi-charged particles in pp collisions at s = 7 TeV using the ATLAS detector
in Physics Letters B
Aad G
(2013)
Measurement of the high-mass Drell-Yan differential cross-section in pp collisions at s = 7 TeV with the ATLAS detector
in Physics Letters B
Aad G
(2012)
Search for the decay B s 0 ? µ + µ - with the ATLAS detector
in Physics Letters B
Aad G
(2013)
Search for single b ? -quark production with the ATLAS detector at s = 7 TeV
in Physics Letters B
Aad G
(2013)
Measurements of Higgs boson production and couplings in diboson final states with the ATLAS detector at the LHC
in Physics Letters B
Aad G
(2014)
Search for Higgs boson decays to a photon and a Z boson in pp collisions at s = 7 and 8 TeV with the ATLAS detector
in Physics Letters B
Aad G
(2013)
A search for prompt lepton-jets in pp collisions at s = 7 TeV with the ATLAS detector
in Physics Letters B
Description | We have built a Grid to analyse data from the LHC at CERN and elsewhere. This enabled the discovery of the Higgs Boson, the fundamental scalar boson that is predicted to give mass to all other particles. |
Exploitation Route | Other disciplines can use our facilities or work with us to develop their own. |
Sectors | Digital/Communication/Information Technologies (including Software) |
URL | http://www.gridpp.ac.uk |
Description | Other disciplines have used our Grid for their own purposes. |
First Year Of Impact | 2008 |
Sector | Creative Economy,Digital/Communication/Information Technologies (including Software),Pharmaceuticals and Medical Biotechnology |
Impact Types | Societal |